BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals
路透社2026/10/09 04:26October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)
October 9 - ** Goldman Sachs points out that India's 30% profit cap on off-schedule anti-cancer drug prices (link) has limited impact on hospitals
** The report states that initial discussions with hospital chain groups indicate such drugs account for less than 5% of hospital revenues and 2% to 2.5% of operating profit
** The report adds that hospitals can offset losses by slightly adjusting service prices, such as administration fees
** The government announcement states that an expert committee will finalize the list of drugs to be regulated
** Affected by the price cap expectation, shares of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had seen an accumulated drop of 11% to 11.5%
** Year to date, FOHE and MAXE are down 11.7% and 14.8% respectively, while APLH is up 11%
(To make it easier for non-English speakers, Reuters has automated the translation of its reports into several other languages. Since automated translation may contain errors or lack necessary context, Reuters does not guarantee the accuracy of this automated translation text and provides it solely for reader convenience. Reuters accepts no liability for any harm or loss arising from the use of the automated translation feature.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ-Humana shares rise on improved “Federal Medicare Advantage Plan” ratings
October 9 – Humana Inc (HUM.N) shares surged 14.4% in pre-market trading to $443. According to U.S. government data, 95% of HUM members participating in the “Medicare Advantage Plan” were rated four stars or higher for 2027. Higher star ratings are crucial for insurance companies, as they result in government bonuses and can boost plan enrollment. Oppenheimer analysts estimate the improved ratings could add $3.6 billion in revenue for the company. In contrast, according to Oppenheimer, competitors UnitedHealth Group (UNH.N) and CVS Health (CVS.N) saw their average ratings fall by 15% from last year, while Elevance (ELV.N) and Centene (CNC.N) also experienced declines. As of the previous trading session, HUM had gained 51% year-to-date, while UNH, CVS, and ELV posted gains between 10% and 14.4%, and CNC surged 57%.
Spotlight Stock Market halts trading in Tessin Nordic on Spotlight Stock Market
Spotlight Group’s Spotlight Stock Market halted trading in Tessin Nordic Holding shares listed on Spotlight Stock Market. Suspension took effect today, Oct. 9, 2026, with trading to remain halted until further notice. Action cited concerns that the company’s shares may not meet Spotlight Stock Market listing requirements. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spotlight Group AB published the original content used to generate this news brief via Cision (Ref. ID: 202610090454BITN____UKPR__SV_20261009-BIT-1178-0) on October 09, 2026, and is solely responsible for the information contained therein.
BUZZ-U.S. telecom stocks fall after SpaceX reaches spectrum agreement
October 9th - SpaceX (SPCX.O) has reached an agreement to acquire a portfolio of nationwide low-frequency spectrum licenses, enabling Starlink Mobile to become a major telecom operator in the US, causing a pre-market decline in US telecom stocks. T-Mobile (TMUS.O) shares fell by 6.3%, AT&T by 5.7%, and Verizon (VZ.N) by 5.1%. According to The Wall Street Journal, citing sources familiar with the matter, SPCX will pay about 8 billion USD in cash to the seller, private equity firm Grain Management, to acquire the asset. The financial terms of the agreement have not yet been disclosed by either party. This deal increases competition for traditional carriers, transforming satellite direct-to-device technology from a supplementary safety feature for remote signal dead zones into a full-fledged commercial competitor replacing terrestrial cellular networks. "Although the three major carriers (T, TMUS, VZ) face a more concrete competitive threat due to their weak performance among high-speed data users (HSDs), this is not entirely unexpected and will most likely begin in rural areas," said Morgan Stanley. So far this year, TMUS is down 15.6%, VZ is up 13.7%, and T is slightly up. European telecom stocks were also impacted, including Germany’s Deutsche Telekom (DTEGn.DE). (To facilitate non-English-speaking users, Reuters automates its reports into several other languages. As automated translations may be inaccurate or lack required context, Reuters does not guarantee the accuracy of automated translations, which are provided solely for reader convenience. Reuters assumes no liability for any harm or loss arising from use of this automated translation feature.)
BUZZ-SpaceX shares rise as it reaches agreement to acquire nationwide low-frequency spectrum portfolio
October 9th - SpaceX (SPCX.O) shares rose 3.8% in pre-market trading to $166.70. The company has reached an agreement to acquire nationwide low-frequency spectrum in order to challenge U.S. wireless carriers, according to The Wall Street Journal. SpaceX will pay about $8 billion to Grain Management for related assets, acquiring radio waves that can travel long distances and penetrate dense structures such as walls. The financial terms of the deal have not yet been disclosed. The acquisition is expected to strengthen the "direct-to-device" service of Starlink Mobile and reduce reliance on traditional base stations. The deal intensifies the competition between satellite communications and cellular networks, increasing the challenges facing existing wireless carriers. The transaction is still subject to approval by the U.S. Federal Communications Commission. As of the close of the previous trading day, SPCX shares had risen more than 18% from the IPO price of $135.
Crypto prices
More
